Clinical Trials on Moderately to Severely Active Crohn's Disease
Total 574 results
-
Alimentiv Inc.TakedaNot yet recruitingCrohn Disease | Moderately to Severely Active Crohn's Disease | Disease Crohn
-
UCB Biopharma S.P.R.L.CompletedModerate and Severe Active Rheumatoid Arthritis | Active Psoriatic Arthritis | Active Ankylosing Spondylitis | Moderately to Severely Active Crohn's DiseaseUnited States
-
AbbViePivotal S.L.; Laboratorio EchevarneCompletedModerate to Severe Crohn's Disease
-
Light Chain Bioscience - Novimmune SACompletedModerate to Severe Crohn's Disease
-
Shanghai Henlius BiotechCompletedModerately to Severely Active Rheumatoid ArthritisChina
-
Everstar Therapeutics LimitedActive, not recruitingModerately to Severely Active Ulcerative ColitisChina
-
TakedaRecruitingModerately to Severely Active Ulcerative ColitisChina
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of PfizerUnknownModerate to Severe Active Axial SpondyloarthritisGermany
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Idera Pharmaceuticals, Inc.CompletedModerate to Severe Plaque Psoriasis | Actively Extending Plaque PsoriasisUnited States
-
Zhejiang Hisun Pharmaceutical Co. Ltd.CompletedModerate to Severe Active Rheumatoid ArthritisChina
-
Synta Pharmaceuticals Corp.CompletedActive, Moderate to Severe Rheumatoid ArthritisNetherlands
-
Aqpha Medical B.V.Not yet recruitingModerate to Severe Nasolabial Fold
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
AllerganCompletedModerate to Severe Nasolabial FoldsGermany, Netherlands
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
JHM BioPharma (Tonghua) Co. , Ltd.Recruiting
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Croma-Pharma GmbHCompleted
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...TerminatedASD Accompanied by Moderate to Severe Gastrointestinal SymptomsChina
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial Folds (NLFs)China
-
Merz North America, Inc.CompletedCorrection of the Moderate to Severe Nasolabial FoldsChina
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Sun Yat-sen UniversityCompletedEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical TreatmentChina
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Hospital Universitari Son DuretaEspen; This research prize was funded by Nestle Nutrition Institute and by...CompletedModerate to Severe Trauma, as Defined by an | Injury Severity Score (ISS) > 12 Points Were Included in the Study.Spain
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
KU LeuvenRecruitingHealthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)Belgium
-
University of LouisvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedMild to Moderately Active Ulcerative ColitisUnited States
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
Immune PharmaceuticalsUnknownUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateIsrael
-
PfizerCompleted
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingActive Moderate to Severe Graves' Orbitopathy
-
Janssen PharmaceuticaWithdrawnModerate to Severe Acute Non-Cancer Pain
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States